tirzepatide fda shortage reconsidering its decision to take off its drug list FDA says tirzepatide shortage is

doi: 10.2337/diabetes.53.3.654 34 DeaconCFPridalLKlarskovLOlesenMHolstJJ

In a double-blind, placebo-controlled, dose-titration study, 1 to 3 g/day of oral propionyl-L-carnitine for 24 weeks was well tolerated and improved maximal walking distance in patients with intermittent claudication (64)

If you have side effects, your healthcare provider can help determine if you need a different dose, a slower titration or a new medication

Robert Kushner Mike Haney: I definitely want to come back to the pharmacotherapies in particular, the concept of metabolic adaptation, which we've been talking about on the show a lot recently